user

Antipsychotic-like effects of the 5-HT2C selective agonist WAY-909 in rodents

被引：0
|
作者：
Rosenzweig-Lipson, S. [1 ]
Sabb, A. [1 ]
Brennan, J. [1 ]
Beyer, C. [1 ]
Comery, T. [1 ]
Piesla, M. [1 ]
Marquis, K. [1 ]
Ashby, C. [2 ]
机构：
[1] Wyeth Ayerst Res, Princeton, NJ 08543 USA
[2] TheraSearch, Sound Beach, NY USA
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2004年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [1] Antidepressant-like effects of the 5-HT2C selective agonist WAY-909 in rodents
    Rosenzweig-Lipson, S.
    Sabb, A.
    Malberg, J.
    Brennan, J.
    Piesla, M.
    Grauer, S.
    Marquis, K.
    Mitchell, P.
    Lucki, I.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 143 - 143
  • [2] Pharmacological characterization of WAY-909, a novel 5-HT2C receptor selective agonist
    Dunlop, J.
    Zhang, J.
    Mazandarani, H.
    Kalgaonker, S.
    Shukhina, E.
    Schechter, L.
    Vogel, R.
    Sabb, A. L.
    Stack, G.
    Rosenzweig-Lipson, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 145 - 145
  • [3] Atypical antipsychotic-like effects of 5-HT2C agonists
    Piesla, MJ
    Comery, TA
    Brennan, JA
    Welmaker, GS
    Rosenzweig-Lipson, S
    Marquis, KL
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 95 - 95
  • [4] Antipsychotic-like effects of SCA-136:: A novel 5-HT2C receptor agonist
    Marquis, KL
    Ator, N
    Dunlop, J
    Ramamoorthy, S
    Beyer, C
    Lin, Q
    Brennan, J
    Piesla, M
    Ashby, C
    Harrison, B
    Magolda, R
    Pangalos, MN
    Stack, G
    Rosenzweig-Lipson, S
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S251 - S252
  • [5] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
    Sharon Rosenzweig-Lipson
    Annmarie Sabb
    Gary Stack
    Paul Mitchell
    Irwin Lucki
    Jessica E. Malberg
    Steve Grauer
    Julie Brennan
    John F. Cryan
    Stacey J. Sukoff Rizzo
    John Dunlop
    James E. Barrett
    Karen L. Marquis
    Psychopharmacology, 2007, 192 : 159 - 170
  • [6] Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
    Rosenzweig-Lipson, Sharon
    Sabb, Annmarie
    Stack, Gary
    Mitchell, Paul
    Lucki, Irwin
    Malberg, Jessica E.
    Grauer, Steve
    Brennan, Julie
    Cryan, John F.
    Rizzo, Stacey J. Sukoff
    Dunlop, John
    Barrett, James E.
    Marquis, Karen L.
    PSYCHOPHARMACOLOGY, 2007, 192 (02) : 159 - 170
  • [7] WAY-163909, a novel selective, 5-HT2C receptor agonist, exhibits an atypical antipsychotic-like profile:: Behavioral, neurochemical and electrophysiological evidence
    Marquis, KL
    Grauer, S
    Brennan, J
    Piesla, M
    Comery, TA
    Sabb, A
    Stack, G
    Dawson, LA
    Ashby, CR
    Meltzer, HY
    Rosenzweig-Lipson, S
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S172 - S172
  • [8] Antiobesity-like effects of the selective 5-HT2C agonist WAY 161503.
    Rosenzweig-Lipson, S
    Coupet, J
    Dunlop, J
    McGonigle, P
    FASEB JOURNAL, 2000, 14 (08): : A1321 - A1321
  • [9] Antipsychotic-like effect by combined treatment with citalopram and WAY 100635:: Involvement of 5-HT2C receptors
    Schilstrom, B.
    Eltayb, A.
    Wadenberg, M. -L. G.
    Svensson, T. H.
    NORDIC JOURNAL OF PSYCHIATRY, 2006, 60 (04) : 336 - 337
  • [10] Antipsychotic-like effect by combined treatment with citalopram and WAY 100635:: involvement of the 5-HT2C receptor
    Eltayb, Amani
    Wadenberg, Marie-Louise G.
    Schilstrom, Bjorn
    Svensson, Torgny H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (03): : 405 - 410
12345